ADVB Estadísticas clave
Alto
18.73
Abrir
8.32
Volumen
23.55M
Bajo
8.08
Cierre anterior
7.08
Valor negociado
312.10M
Máx. 52 sem.
18.73
Volumen rel.
5.794
Amplitud (%)
150.42%
Mín. 52 sem.
3.61
Tasa de rotación
1425.97%
Cap. de Mercado
11.69M
PER (TTM)
44.47
PER (Anual)
--
P/B
1.27
P/S
--
Beneficio por acción (BPA)
0.159
Dividendo (TTM)
0
Rentabilidad por dividendo
0.00%
Acciones en circulación
1.65M
Moneda
USD
ADVB Rendimiento del Precio
7 día
30 día
90 día
180 día
En lo que va del año
1 Año
ADVB Distribución del flujo de dinero
ADVB Volumen diario de ventas en corto
ADVB Historial de short interest
Resumen de la acción ADVB
As of 2026-07-22, the Advanced Biomed Inc. (ADVB) stock price today is 12.41. Based on this price, the company has a market capitalization of $11.69M, with a P/E ratio of 44.47.
On 2026-07-22, ADVB traded between 8.08 and 18.73. Today’s stock price is 53.59% above the daily low and 33.74% below the daily high, placing ADVB cerca de la mitad de its most recent trading range.
Trading volume currently stands at 23.55M, compared with an average daily volume of 4.06M. This suggests that trading activity is significativamente por encima de su nivel habitual than usual.
Over the past year, Advanced Biomed Inc. shares have traded between 3.61 and 18.73. At today’s price, ADVB is 243.77% above its 52-week low and 33.74% below its 52-week high.
ADVB Noticias relacionadas
Acerca de ADVB
Nombre empresa
Advanced Biomed Inc.
Sector
Health Technology
Industria
Biotechnology
Intercambios
Nasdaq
Número de empleados
31
Tamaño del lote
100
Sitio oficial
Moneda
USD
Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.
Related Stocks
ADVB FAQ
© 2026 CoinGlass, all rights reserved
